For its full members The Virus Project provides these two reports. A $750 Value. Foundational knowledge of COVID.
US Report. Provides an overview of the scientific, regulatory and market issues for the COVID-19 testing market in the US and Europe. This market did not exist in January 2020 but could reach $20 billion in revenues in 2021.
- Growth Model on the potential size of the market and the various market segments. It includes an analysis of the impact on public stocks by COVID-19 during spring of 2020.
- Summary of core testing technologies. Molecular (PCR) tests and Serology IgM, IgA, IgG with a discussion of types of immunoassays for antibody detection.
- Identifies emerging testing technologies including: Isothermal nucleic acid amplification; CT imaging; CRISPR; Machine Learning; Rapid Antigen; Neutralization Assays; NGS and Monitoring host immune response
- Insights on the complimentary products and supply chain with summaries of Molecular Tests, Swabs and Serology Tests.
- Regulatory analysis of the FDA with a discussion of validation FDA notification and issues after EUA submission.
- Health insurance regulation and coverage. A summary of how the US government and the rules under which the health providers are expected to operate.
- Market size for PCR and Antibody tests
- Different business models employed
- Regulatory pathways
- Supply chain analysis including bottlenecks.
- Regulatory landscape. Including a detailed flow chart analyzing zing the complexity of approval process in the EU, China and South Korea
- Commercialization landscape in Europe
- Reimbursement analysis for France, Germany, UK, Spain and Italy, US, China and India.
